about
Peptide products of the neurotrophin-inducible gene vgf are produced in human neuroendocrine cells from early development and increase in hyperplasia and neoplasiaLanreotide in metastatic enteropancreatic neuroendocrine tumorsGastroenteropancreatic neuroendocrine tumoursPathology reporting of neuroendocrine tumors: application of the Delphic consensus process to the development of a minimum pathology data set.Molecular aspects of the endocrine tumours of the pancreas and the gastrointestinal tract.Immune response to Mycobacterium tuberculosis infection in the parietal pleura of patients with tuberculous pleurisy.Well-differentiated gastric tumors/carcinomas.Italian Association of Clinical Endocrinologists (AME) position statement: a stepwise clinical approach to the diagnosis of gastroenteropancreatic neuroendocrine neoplasms.Transient expression of secretin in serotoninergic neurons of mouse brain during development.Neuromyelitis optica spectrum disorder as a paraneoplastic manifestation of lung adenocarcinoma expressing aquaporin-4.Genetic alterations in combined neuroendocrine neoplasms of the lung.Highlights of the biology of endocrine tumours of the gut and pancreas.The phenotype of gut endocrine tumours.The "normal" endocrine cell of the gut: changing concepts and new evidences.TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system.Mice transgenic for a vasopressin-SV40 hybrid oncogene develop tumors of the endocrine pancreas and the anterior pituitary. A possible model for human multiple endocrine neoplasia type 1.Ghrelin expression and actions: a novel peptide for an old cell type of the diffuse endocrine system.Enteroendocrine precursors differentiate independently of Wnt and form serotonin expressing adenomas in response to active beta-catenin.Endocrine tumours of the gastrointestinal tract: aetiology, molecular pathogenesis and genetics.The grey zone between pure (neuro)endocrine and non-(neuro)endocrine tumours: a comment on concepts and classification of mixed exocrine-endocrine neoplasms.Criteria for malignancy in gastrointestinal endocrine tumors.Well-differentiated duodenal tumor/carcinoma (excluding gastrinomas).Well-differentiated pancreatic tumor/carcinoma: insulinoma.HPV infection in squamous cell carcinomas arising from different mucosal sites of the head and neck region. Is p16 immunohistochemistry a reliable surrogate marker?TNM staging of midgut and hindgut (neuro) endocrine tumors: a consensus proposal including a grading system.Site-specific biology and pathology of gastroenteropancreatic neuroendocrine tumors.Three different synchronous primary lung tumours: a case report with extensive genetic analysis and review of the literature.Natural history, clinicopathologic classification and prognosis of gastric ECL cell tumors.Endocrine hyperplasia and dysplasia in the pathogenesis of gastrointestinal and pancreatic endocrine tumors.Prognostic factors in gastrointestinal endocrine tumors.ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: towards a standardized approach to the diagnosis of gastroenteropancreatic neuroendocrine tumors and their prognostic stratification.Treatment of malignant pancreatic neuroendocrine neoplasms: middle-term (2-year) outcomes of a prospective observational multicentre study.Uterine carcinosarcoma metastatic to the lung as large-cell neuroendocrine carcinoma with synchronous sarcoid granulomatosis.Gastric argyrophil carcinoidosis in patients with Zollinger-Ellison syndrome due to type 1 multiple endocrine neoplasia. A newly recognized association.Distinct cellular origins for serotonin-expressing and enterochromaffin-like cells in the gastric corpusENETS consensus guidelines for the management of peritoneal carcinomatosis from neuroendocrine tumors.Pathology of gastrointestinal disorders.The pathological diagnosis of neuroendocrine tumors: common questions and tentative answers.Gastroenteropancreatic (neuro)endocrine neoplasms: the histology report.Neuroendocrine neoplasms of the gut and pancreas: new insights.
P50
Q24303118-35A56405-5E8F-4B73-B0BF-9AA98549C995Q28243728-FB0C9B9B-DA36-4DD2-A678-7CBE2DEFDB05Q28263732-2EFD0349-4962-4A53-988E-91A53C296256Q33527776-59798968-19B3-47EA-8232-A39F0E10DB07Q33798723-4DE41325-1CC9-43F0-A6F7-F8FED22C395CQ33987707-4BD3BD7A-1191-487B-BEB3-0B722DF4134CQ34002549-800DD480-265C-474B-A3FD-06FB59ED9F9AQ34157385-01096FC8-722D-468F-AAFC-D8078E9CF2DCQ34378160-762E1608-1F1F-42D7-98DF-B6E220DB2DEEQ34464610-567DE38B-AD4F-4A92-8147-2032D64070B1Q34737984-B9530E05-1499-432A-A05C-416C93C82429Q35624468-9445F76D-00AE-40BB-A833-754FE81FAB2DQ35743377-94CF81CE-1FFA-4B5C-AD49-BD6C5F2FFDEFQ35778197-101EF0BD-AF4B-41C4-9CE3-3B675A317030Q35837124-6D6C2F80-4AA5-4749-B759-2B24F8668D62Q35856545-E0789FF0-0337-46C1-B88C-302DDF45069EQ35937663-77269A8E-FB25-45F9-8065-7D8D698DB424Q36090168-B7B6A837-228C-4B44-8F52-D4C941566CD6Q36267613-E8F94D93-1127-4863-BAE3-C79E6085E9C6Q36620486-A6CC8F04-0872-4017-BCB1-9E3B801BDF4EQ36678870-CCD166C6-17C7-4490-AF3D-2D6BF773272FQ36741113-209DB0FD-CEB4-4682-9868-DE653DEE3874Q36741120-6757595C-B850-4B79-B8BD-D21F2C8A0550Q36746765-4F8DE083-C3CB-46C2-B6A2-18D3410FC4C5Q36900877-E1E3D158-0694-4553-B89B-5A02D0A482F2Q36904558-6EBB4860-00F4-4E6A-A235-11292ED9AE2CQ36914154-F9F3248E-F7F5-4AAA-8390-1B1955EF6CCDQ36963098-0CB8E9CC-A32B-4F35-AC34-93C97D436D92Q36998491-27659950-3D58-4889-BA1A-B7250ABA68B4Q37023941-D4D7E31D-EA23-445E-A63E-AF3C53D2CB45Q37342488-1D9671E3-1E1F-44F9-BE10-96A45C86DF97Q37350299-40650A83-30B1-457A-BA12-47505B11A510Q37359335-AEC15E5D-7CC0-4613-8425-7D7FD0E1722FQ37587427-23A8A0ED-4C95-4A8A-934A-0455FC5D4B29Q37620107-D127B120-A6DE-47B4-A591-879EEC0ABC63Q37737927-9EA1B3D5-4CF6-4F1C-A597-F1A7608AE7BAQ37811558-5268CAB2-21B9-4260-9125-FCA98AF8E005Q37846130-75A7E292-D4FB-4E4D-925A-690D5FF16CB6Q37860678-397E84AF-2154-4F3B-B749-FFFCFE5BFACFQ37909911-8CFA460D-F4F2-4ADE-A6D5-B9D301AA8B66
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Guido Rindi
@ast
Guido Rindi
@en
Guido Rindi
@es
Guido Rindi
@nl
type
label
Guido Rindi
@ast
Guido Rindi
@en
Guido Rindi
@es
Guido Rindi
@nl
altLabel
Guido RINDI
@en
prefLabel
Guido Rindi
@ast
Guido Rindi
@en
Guido Rindi
@es
Guido Rindi
@nl
P106
P1153
55577742100
P214
9221153063156019320002
P31
P496
0000-0003-2996-4404
P735
P7859
viaf-9221153063156019320002